Cellular Biomedicine Group’s C-CAR039 Receives NMPA Approval for B-Cell NHL Study
China-based Cellular Biomedicine Group Inc. (CBMG), a private company following a merger deal in February...
Cell-therapy
Global Cord Blood Corp’s Cellenkos Gets FDA Nod for Myelofibrosis Trial
Global Cord Blood Corporation (GCBC; NYSE: CO) announced receiving Investigational New Drug (IND) approval from...
WuXi ATU Partners with Wugen to Accelerate NK Cell Therapy Development
WuXi ATU, the gene and cell therapy-focused CTDMO unit of WuXi Apptec (SHA: 603259, HKG:...
Ascentage Pharma’s Lisaftoclax Shows Promising Results in Phase I Trial for Non-Hodgkin Lymphoma
Suzhou-based Ascentage Pharma (HKG: 6855) announced the publication of Phase I clinical study results for...